Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chamaemelum nobile, widely known as Roman chamomile, is a perennial flowering herb in the Asteraceae family. It is a prominent medicinal plant historically utilized in traditional medicine for its anti-inflammatory, antioxidant, antimicrobial, and sedative properties. The plant's chemical profile is characterized by a high concentration of essential oils, including angelic acid esters (such as 3-methylpentyl angelate), as well as flavonoids (notably apigenin), coumarins, and germacrane-type sesquiterpene lactones like nobilin. Pharmacological research indicates that C. nobile can inhibit key pro-inflammatory mediators such as Interleukin-6 (IL-6), Tumor Necrosis Factor alpha (TNF-α), and Monocyte Chemoattractant Protein-1 (MCP-1). It also demonstrates inhibitory activity against enzymes such as acetylcholinesterase and tyrosinase, suggesting potential applications in neurodegenerative and skin disorders. Clinically, it has been investigated as a 2% topical gel for managing Oral Lichen Planus (OLP) as a safer alternative to corticosteroids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chamaemelum nobile.